GlobeNewswire Inc.··The Schall Law FirmImmunityBio Securities Fraud Class Action Seeks Investors Amid Anktiva Claims
Schall Law Firm launches class action lawsuit against ImmunityBio for alleged securities fraud over false Anktiva drug statements between January-March 2026.
IBRXsecurities fraudclass action lawsuit